rs758738508
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_020376.4(PNPLA2):c.425A>G(p.Asn142Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,613,612 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020376.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA2 | ENST00000336615.9 | c.425A>G | p.Asn142Ser | missense_variant | Exon 4 of 10 | 1 | NM_020376.4 | ENSP00000337701.4 | ||
PNPLA2 | ENST00000525250.5 | n.1031A>G | non_coding_transcript_exon_variant | Exon 2 of 6 | 2 | |||||
PNPLA2 | ENST00000534561.1 | n.92A>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
PNPLA2 | ENST00000531923.1 | n.-54A>G | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151922Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251362Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135898
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461690Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727136
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151922Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74204
ClinVar
Submissions by phenotype
Neutral lipid storage myopathy Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 142 of the PNPLA2 protein (p.Asn142Ser). This variant is present in population databases (rs758738508, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PNPLA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 465794). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.425A>G (p.N142S) alteration is located in exon 4 (coding exon 3) of the PNPLA2 gene. This alteration results from a A to G substitution at nucleotide position 425, causing the asparagine (N) at amino acid position 142 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at